Biological
GARDASIL®9 (Human Papillomavirus 9-valent Vaccine, Recombinant)
Total Trials
1
Max Phase
-
Type
BIOLOGICAL
Molecule
-
Registry-listed formulations
This catalogue entry has no confirmed scientific concept.
Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.
0 source entries across 0 studies. This list may not include all unresolved or historical entries.
Success Metrics
Active Trials
0(0%)
Phase Distribution
Phase 1/2
1
100%
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution1 total trials
Phase 1/2Combined phases
1(100.0%)
Highest Phase Reached
Phase 1/2Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
1
all time
Status Distribution
Active(1)
Detailed Status
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
1
Active
0
Success Rate
N/A
Most Advanced
Phase 1/2
Trials by Phase
Phase 1/21 (100.0%)
Trials by Status
not_yet_recruiting1100%
Recent Activity
Clinical Trials (1)
Drug Details
- Intervention Type
- Biological
- Total Trials
- 1